Zusammenfassung
Das atopische Ekzem (AE) zählt in Deutschland zu den häufigsten chronisch-entzündlichen Erkrankungen und ist einer der Hauptgründe, einen Hautarzt aufzusuchen. In den letzten Jahren wuchs das Kenntnis um die zellulären, molekularen und immunologischen Zusammenhänge sowie genetischen Veränderungen rasant. Dies ermöglicht ein besseres Verständnis der Erkrankung. Konsequenterweise befinden sich aktuell innovative zielgerichtete Therapien in klinischer Entwicklung bzw. bereits in der Zulassung. Um aber diese neuen Therapien sinnvoll einsetzen zu können, ist ein noch genaueres Verständnis der Pathogenese wichtig. In Zukunft werden die Stratifizierung von Patienten mit AE und die daraus folgende personalisierte Therapie an Bedeutung gewinnen. In der vorliegenden Übersicht wird der aktuelle Kenntnisstand der komplexen Pathogenese des AE dargestellt.
Abstract
Atopic dermatitis (AD) is one of the most common chronic inflammatory diseases and is also one of the most frequent reasons to consult a dermatologist. Over the past few years there has been a rapidly growing understanding of the cellular, molecular and immunological relationships as well as genetic variations, which leads to a better comprehension of the disease. Consequently, there are innovative targeted therapies in clinical studies or already approved for therapy. To make reasonable use of the new targeted therapies a good understanding of the pathogenesis is very important. In the future, stratification of patients with AD and the resulting personalized therapies will gain in importance. This review depicts the up to date state of knowledge on the complex pathogenesis of AD.
Abbreviations
- AD:
-
„Atopic dermatitis“
- AE:
-
Atopisches Ekzem (Neurodermitis)
- AMP:
-
Antimikrobielle Peptide
- FLG:
-
Filaggrin (Strukturprotein)
- HR4:
-
Histamin-4-Rezeptor
- IDEC:
-
Inflammatorische dendritische epidermale Zellen
- Ig:
-
Immunglobulin
- IL:
-
Interleukin
- LEKTI:
-
„Lympho-epithelial Kazal-type-related inhibitor“
- S. aureus :
-
Staphylococcus aureus
- Th-Zellen:
-
T-Helfer-Zellen
- TSLP:
-
„Thymic stromal lymphopoietin“
Literatur
Trautmann A et al (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106(1):25–35
Asher MI et al (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368(9537):733–743
Schmitt J et al (2009) Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges 7(4):345–351
Quaranta M et al (2014) Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med 6(244):244ra90
Eyerich S et al (2011) Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 365(3):231–238
Rodriguez E et al (2009) Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 123(6):1361–1370.e7
Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365(14):1315–1327
Jarrett R et al (2016) Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase. Sci Transl Med 8(325):325ra18
Barnes KC (2010) An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 125(1):16–29.e1–11 (quiz 30–1)
Ferreira MA et al (2017) Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet 49(12):1752. https://doi.org/10.1038/ng.3985
Paternoster L et al (2015) Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet 47(12):1449–1456
Kezic S et al (2014) Skin barrier in atopic dermatitis. Front Biosci (Landmark Ed) 19:542–556
Ishikawa J et al (2010) Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 130(10):2511–2514
Werfel T et al (2015) Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol 136(1):96–103.e9
Jungersted JM et al (2010) Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 65(7):911–918
Voegeli R et al (2009) Increased stratum corneum serine protease activity in acute eczematous atopic skin. Br J Dermatol 161(1):70–77
Suarez-Farinas M et al (2011) Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127(4):954–964.e1–4
Wollenberg A, Rawer HC, Schauber J (2011) Innate immunity in atopic dermatitis. Clin Rev Allergy Immunol 41(3):272–281
Eyerich K et al (2009) IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123(1):59–66.e4
Morizane S et al (2012) TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. J Allergy Clin Immunol 130(1):259–261.e1
Guttman-Yassky E, Nograles KE, Krueger JG (2011) Contrasting pathogenesis of atopic dermatitis and psoriasis – part I: clinical and pathologic concepts. J Allergy Clin Immunol 127(5):1110–1118
Guttman-Yassky E, Nograles KE, Krueger JG (2011) Contrasting pathogenesis of atopic dermatitis and psoriasis – part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 127(6):1420–1432
Roesner LM et al (2015) Der p1 and der p2-specific T cells display a th2, th17, and th2/th17 phenotype in atopic dermatitis. J Invest Dermatol 135(9):2324–2327
Eyerich S et al (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119(12):3573–3585
Eyerich K, Novak N (2013) Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 68(8):974–982
Kopfnagel V, Harder J, Werfel T (2013) Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr Opin Allergy Clin Immunol 13(5):531–536
Kim EH et al (2015) Indoor air pollution aggravates symptoms of atopic dermatitis in children. PLoS ONE 10(3):e119501. https://doi.org/10.1371/journal.pone.0119501
Bergmann MM et al (2013) Evaluation of food allergy in patients with atopic dermatitis. J Allergy Clin Immunol Pract 1(1):22–28
Mommert S et al (2011) The role of the histamine H4 receptor in atopic dermatitis. Curr Allergy Asthma Rep 11(1):21–28
Werfel T et al (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138(2):336–349
Ruzicka T et al (2017) Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. N Engl J Med 376(9):826–835
Steinhoff M et al (2006) Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 126(8):1705–1718
Mollanazar NK, Smith PK, Yosipovitch G (2016) Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? Clin Rev Allergy Immunol 51(3):263–292
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Scheerer und K. Eyerich geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Scheerer, C., Eyerich, K. Pathogenese des atopischen Ekzems. Hautarzt 69, 191–196 (2018). https://doi.org/10.1007/s00105-018-4127-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-018-4127-4